Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth
A federal judge ruled Abbott must face a lawsuit claiming its PediaSure drinks were falsely marketed as clinically proven to help children grow.Summary
On June 4, US District Judge Paul Engelmayer ruled that Abbott Laboratories must face a proposed class‑action lawsuit alleging it misled consumers by marketing PediaSure Grow & Gain drinks as “clinically proven” to help children grow, arguing that the giraffe‑and‑ruler labeling could be interpreted as promising height and weight gain. The judge said jurors could find the company’s commercials reinforced that message, citing an ad showing a boy comparing himself to taller peers. Abbott maintains its labeling is “appropriate” and backed by evidence, while plaintiff Joanne Noriega said her grandson remained short after a year of daily use but became overweight. Abbott, which operates through Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices segments, also noted the lawsuit will proceed. The article concludes with a promotional note about AI stocks unrelated to the legal matter.
(Source：Insider Trading)